Nombre del producto:1-(2-allyloxy-5-bromo-phenyl)hexahydropyrimidine-2,4-dione

IUPAC Name:1-[5-bromo-2-(prop-2-en-1-yloxy)phenyl]-1,3-diazinane-2,4-dione

CAS:2703772-19-2
Fórmula molecular:C13H13BrN2O3
Pureza:95%
Número de catálogo:CM1076088
Peso molecular:325.16

Unidad de embalaje Stock disponible Precio($) Cantidad

Sólo para uso en I+D..

Formulario de consulta

   refresh    

Detalles del producto

Núm. De CAS :2703772-19-2
Fórmula molecular:C13H13BrN2O3
Punto de fusión:-
Código de sonrisas:BrC1=CC(N2CCC(=O)NC2=O)=C(OCC=C)C=C1
Densidad:
Número de catálogo:CM1076088
Peso molecular:325.16
Punto de ebullición:
Nº Mdl:
Almacenamiento:

Category Infos

PROTAC-E3 Ligase Ligands
Bifunctional degrader molecules, also called proteolysis-targeting chimeras (PROTACs), are a new modality of chemical tools and potential therapeutics to understand and treat human disease. A required PROTAC component is a ligand binding to an E3 ubiquitin ligase, which is then joined to another ligand binding to a protein to be degraded via the ubiquitin–proteasome system. The advent of nonpeptidic small-molecule E3 ligase ligands revolutionized the field and ushered in the design of drug-like PROTACs with potent and selective degradation activity.
PROTAC-E3 Ligase Ligands | PROTACs | Bifunctional Degrader Molecules
Proteolysis-Targeting Chimeras | PROTAC-E3 Ligase Ligands | PROTACs | Bifunctional Degrader Molecules
PROTAC (Proteolysis-Targeting Chimeras) is a promising approach in drug discovery that involves the use of small molecules to target specific proteins for degradation by the cellular machinery.

Related Products